Clinical study of Garenoxacin on male non-gonococcal urethritis
Not Applicable
Recruiting
- Conditions
- on-gonococcal urethritis
- Registration Number
- JPRN-UMIN000014994
- Lead Sponsor
- Jikei university katsushika medical center,Department of urology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with a history of allergies against fluoroquinolone. Patient with convulsive disorders like epilepsy or with a history of these deseases. Patients who have severe heart diseases including inchemic heart diseases or arrthythmia. Patient with diabetis mellitus. Patient with systolic blood pressure of patients below 90mmHg. Patient with myasthenia gravis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Garenoxacin's efficacy against Mycoplasma genitalium in male non-gonococcal urethritis?
How does Garenoxacin compare to doxycycline in treating male non-gonococcal urethritis efficacy and safety?
Which biomarkers predict response to Garenoxacin in Mycoplasma genitalium-associated non-gonococcal urethritis?
What are the adverse event profiles and management strategies for Garenoxacin in male NGU patients?
Are there combination therapies or alternative quinolones showing improved outcomes for male non-gonococcal urethritis compared to Garenoxacin?